Recent News

• 03.26.2026 - Inspira Technologies Reports Full Year 2025 Financial Results and Provides Business Updates
• 02.18.2026 - Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State
• 02.17.2026 - Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks

Recent Filings

• 03.24.2026 - 3 Initial statement of beneficial ownership of securities
• 03.19.2026 - 3 Initial statement of beneficial ownership of securities
• 03.19.2026 - 3 Initial statement of beneficial ownership of securities
• 03.19.2026 - 3 Initial statement of beneficial ownership of securities
• 03.19.2026 - 3 Initial statement of beneficial ownership of securities
• 03.19.2026 - 3 Initial statement of beneficial ownership of securities
• 03.19.2026 - 3 Initial statement of beneficial ownership of securities
• 03.05.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.25.2026 - EX-99.1 EX-99.1
• 02.25.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]